Military Medical Board - CAMP BLISS, Texas -- The United States is constantly seeking new technologies and testing new tools to increase survivability on the battlefield. Recently, the US Department of Medicine board conducted a trial on an intrathoracic pressure regulation therapy (IPRT) device that research hopes will help save the lives of critically injured patients.

The IPRT device raises blood pressure and increases blood flow to body tissues in patients with low blood volume. Cleared by the Food and Drug Administration, IPRT non-invasively reduces intrathoracic pressure by increasing blood flow. It is useful for patients with compromised blood flow from shock, cerebral hypertension and other low perfusion conditions. The IPRT device is connected to the breathing circuit of a ventilated patient and is useful for patients with compromised blood flow due to shock, intracranial hypertension and other low perfusion conditions.

Military Medical Board

Military Medical Board

Sergeant 1st Class Jacob Horspool was assigned to the AMEDD Center and School, a health readiness center on the AMEDD board, serving as the test officer in charge. "This device directs blood back to the heart and lungs, while reducing the pressure in the brain that causes swelling," said Horspool. "If a patient has a good pair of lungs, we can use this device to restore blood without adding extra fluids that might thin the blood." He continued.

The Flying Hospital That Rushes Wounded Soldiers To Safety

Soldiers from various medical units served as test players in real-world deployment scenarios during operational testing. For testing, the AMEDD board brings in potential IPRT users; Pulmonary Officer, Emergency Medicine Physician, Attending Physician, Nurses, Combat Physicians, Operating Room Specialists, Paramedics/Aeromedical Specialists and Respiratory Specialists. Testing at Camp Bliss allowed the team to use the device inside a combat support hospital and in field ambulances on different power sources.

Warrant Officer Two Goldie Cooper assisted with testing and was also assigned to the AMEDD board. Cooper said testing the engine in the field is an important first step towards purchasing and adding them to the roster. He pointed out that the operational test is where it is identified whether the device is suitable for use in the operational environment.

An estimated 90% of possible survivor deaths (approximately 1,080) in Operation Iraqi Freedom were caused by hemorrhage and hemorrhagic shock. In all documented wars, exsanguination, haemorrhage, and hemorrhagic shock are the leading causes of combat deaths. Cooper said, "Ultimately, it comes down to survival and life recovery rates on the battlefield. Every minute counts when you're trying to save lives."

When testing is complete, the AMEDD board testing team prepares a summary report that assesses the suitability and effectiveness of the IPRT. The instrument will undergo several reviews to ensure it meets the requirements before being approved and implemented.

Pdf) Military Medical Research Calls For Paper

Military medical programs, military medical malpractice cases, military medical malpractice, medical board military, military board, military medical evaluation board, military load board, bote board military discount, military medical review board, military medical waiver form, military medical board process, military medical malpractice lawyer